Laura Caquelin

Artiklar

Article: RESEARCH SYNTHESIS METHODS. 2024;15(6):964-977
Meta-analyses of phase I dose-finding studies: Application for the development of protein kinase inhibitors in oncology
Caquelin L; Badra P; Poulain L; Laviolle B; Ursino M; Locher C
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;152(12):2474-2484
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020
Gloy V; Schmitt AM; Dueblin P; Hirt J; Axfors C; Kuk H; Pereira TV; Locher C; Caquelin L; Walter-Claudi M; Lythgoe MP; Herbrand A; Kasenda B; Hemkens LG
Article: THERAPIE. 2022;77(2):207-217
Pharmacology and pharmacovigilance of protein kinase inhibitors
Khouri C; Mahe J; Caquelin L; Locher C; Despas F
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2021;137:241-249
Intent to share Annals of Internal Medicine's trial data was not associated with data re-use
Pellen C; Caquelin L; Bail AJ-L; Gaba J; Verin M; Moher D; Ioannidis JPA; Naudet F
Article: BMJ OPEN. 2020;10(5):e038887
Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations.
Siebert M; Gaba JF; Caquelin L; Gouraud H; Dupuy A; Moher D; Naudet F

Editorial comment: PLOS BIOLOGY. 2024;22(12):e3002953
Public engagement with research reproducibility
Vinatier C; Kozula M; van den Eynden V; Caquelin L; Roubik H; Stegeman I; Naudet F
Review: PEERJ. 2023;11:e16016
Assessing the magnitude of changes from protocol to publication-a survey on Cochrane and non-Cochrane Systematic Reviews
Siebert M; Caquelin L; Madera M; Acosta-Dighero R; Naudet F; Roque M
Editorial comment: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2022;149:183-189
Meta-research studies should improve and evaluate their own data sharing practices
Cristea IA; Naudet F; Caquelin L
Review: BMC CANCER. 2022;22(1):381
Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature
Caquelin L; Gewily M; Mottais W; Tebaldi C; Laviolle B; Naudet F; Locher C